Healthcare stocks join the broader market rally as 94% of the MondayMorning subgroup basket gain ground.

Healthcare stocks skyrocketed the week of November 1, 2019, fueled by a bull market that traces its roots to the depths of the financial crisis. Upward momentum is revving up… Read more »

ProPublica reports that more than 700 doctors were paid over a million dollars each in 2018 by drug and medical device firms. How industry money reaches physicians.

ProPublica, a nonprofit newsroom that investigates abuses of power, has been tracking drug company spending on doctors since 2010. It just updated its database and found that companies are still… Read more »

Health stocks shine on Wall Street as Medicare for All shows signs of slippage.

Support for Medicare for All is showing signs of slippage as top-tier Democratic presidential candidates Sens. Elizabeth Warren and Bernie Sanders struggle to sell the proposal without providing specifics on… Read more »

Health sector IPOs show no sign of cooling off as “rain dance” continues, and new money keeps showering hopefuls.

With signs that public support of Medicare for All is slipping, health-sector IPO action was on fire last week and, in general, there could be eight new IPOs priced this… Read more »

Sackler Family, Purdue Pharma not the only ones to blame for US opiod crisis. Not by a long shot.

The News: After months of negotiations and threats, Purdue Pharma LP (Stamford CT) finally filed for bankruptcy earlier this week. But it’s hardly a done deal, according to The New York Times…. Read more »

FDA goes on a rulings binge

      No Comments on FDA goes on a rulings binge

FDA ROUNDUP: In one of the busiest rulings binges of the year, the US Food and Drug Administration last week approved an assortment of pharmaceuticals, medical devices, an AI algorithm… Read more »

Health-sector IPO action heating up big time after Labor Day pause.

Health-sector initial public offerings are alive and kicking again, as over $1B was raised last week among just for aspiring players, now taking their chances in the big league stock… Read more »

Health-sector stocks mostly up after nerve-racking presidential debate.

Winners barely beat out losers last week as health care outshone climate change and gun control (among other topics) at the latest Democratic debate last week. (See our broader health-sector… Read more »

Op-ed piece on “Quantity- versus quality-of-life for stage IV cancer patients: What my younger brother learned first-hand and later taught me.”

The News: A new, provocative study published in March in the journal Cancer sheds some light on the relationship between patients’ belief about their likely curability and the trade-offs they are prepared… Read more »